Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2005 1
2006 1
2007 1
2008 1
2009 1
2010 1
2011 1
2012 1
2013 1
2014 1
2016 1
2018 2
2019 1
2020 2
2021 3
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

17 results
Results by year
Filters applied: . Clear all
Page 1
6-month SARS-CoV-2 antibody persistency in a Tyrolian COVID-19 cohort.
Deisenhammer F, Borena W, Bauer A, Kimpel J, Rudzki D, Schanda K, Egeter J, Hüfner K, Sperner-Unterweger B, Reindl M. Deisenhammer F, et al. Among authors: rudzki d. Wien Klin Wochenschr. 2021 Apr;133(7-8):351-358. doi: 10.1007/s00508-020-01795-7. Epub 2020 Dec 9. Wien Klin Wochenschr. 2021. PMID: 33315138 Free PMC article.
12-month SARS-CoV-2 antibody persistency in a Tyrolean COVID-19 cohort.
Deisenhammer F, Bauer A, Kavelar C, Rudzki D, Rössler A, Kimpel J, Borena W, Reindl M. Deisenhammer F, et al. Among authors: rudzki d. Wien Klin Wochenschr. 2021 Dec;133(23-24):1265-1271. doi: 10.1007/s00508-021-01985-x. Epub 2021 Nov 23. Wien Klin Wochenschr. 2021. PMID: 34812944 Free PMC article.
Intraepidermal Nerve Fiber Density in Friedreich's Ataxia.
Indelicato E, Nachbauer W, Eigentler A, Rudzki D, Wanschitz J, Boesch S. Indelicato E, et al. Among authors: rudzki d. J Neuropathol Exp Neurol. 2018 Dec 1;77(12):1137-1143. doi: 10.1093/jnen/nly100. J Neuropathol Exp Neurol. 2018. PMID: 30358880
Cytokine profiles show heterogeneity of interferon-β response in multiple sclerosis patients.
Hegen H, Adrianto I, Lessard CJ, Millonig A, Bertolotto A, Comabella M, Giovannoni G, Guger M, Hoelzl M, Khalil M, Fazekas F, Killestein J, Lindberg RL, Malucchi S, Mehling M, Montalban X, Rudzki D, Schautzer F, Sellebjerg F, Sorensen PS, Deisenhammer F, Steinman L, Axtell RC. Hegen H, et al. Among authors: rudzki d. Neurol Neuroimmunol Neuroinflamm. 2016 Jan 27;3(2):e202. doi: 10.1212/NXI.0000000000000202. eCollection 2016 Apr. Neurol Neuroimmunol Neuroinflamm. 2016. PMID: 26894205 Free PMC article.
Natalizumab treatment reduces endothelial activity in MS patients.
Millonig A, Hegen H, Di Pauli F, Ehling R, Gneiss C, Hoelzl M, Künz B, Lutterotti A, Rudzki D, Berger T, Reindl M, Deisenhammer F. Millonig A, et al. Among authors: rudzki d. J Neuroimmunol. 2010 Oct 8;227(1-2):190-4. doi: 10.1016/j.jneuroim.2010.07.012. Epub 2010 Aug 23. J Neuroimmunol. 2010. PMID: 20739072
17 results